Polycystic Ovary Syndrome

The first Friday in February is Wear Red Day. In support of increasing awareness of women’s heart health, Healio | Cardiology Today compiled a list of recent news and updates on women and CVD research.

Dysmenorrhea and polycystic ovary syndrome are linked to a long-term increased risk for CVD in women, according to a presentation at the American Heart Association Scientific Sessions.

PHILADELPHIA — Two common reproductive health conditions, dysmenorrhea and polycystic ovary syndrome, are associated with increasing CVD risk in women, according to research presented at the American Heart Association Scientific Sessions.

Women with a history of infertility who use assisted reproductive technologies may have increased risk for CVDs, such as preeclampsia, stroke and heart failure, according to a presenter.

The FDA’s approval of Cosentyx leads Healio Dermatology’s most read articles this year about hidradenitis suppurativa.

Since deciding in high school to become a physician, William E. Gibbons, MD, never had the desire to be anything other than who he is today, a self-proclaimed science nerd.

DENVER — For women with polycystic ovary syndrome, therapeutic lifestyle modifications help to regulate menstruation, improve glucose metabolism and increase fertility, according to a speaker at the Lifestyle Medicine Conference.

Study data suggest that children and adolescents with a high polygenic risk score for polycystic ovary syndrome tend to have a higher BMI and are more likely to develop obesity.

Children and adolescents with a high polygenic risk score for polycystic ovary syndrome tend to have a higher BMI and are more likely to develop obesity, according to study data.

In the past 2 decades, metformin has become a mainstay of type 2 diabetes management and is now the recommended first-line drug for treating the disease in the United States and worldwide.